CANCER TREATMENT-INDUCED THROMBOCYTOPENIA (CTIT)

Clinical trials for CANCER TREATMENT-INDUCED THROMBOCYTOPENIA (CTIT) explained in plain language.

Never miss a new study

Get alerted when new CANCER TREATMENT-INDUCED THROMBOCYTOPENIA (CTIT) trials appear

Sign up with your email to follow new studies for CANCER TREATMENT-INDUCED THROMBOCYTOPENIA (CTIT), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug aims to rescue platelet levels in leukemia patients

Disease control Recruiting now

This trial tests a drug called romiplostim N01 in people with leukemia who develop dangerously low platelet counts from their cancer treatment. The goal is to see if weekly injections can safely raise platelet levels and reduce the need for transfusions. The study involves about …

Matched conditions: CANCER TREATMENT-INDUCED THROMBOCYTOPENIA (CTIT)

Phase: PHASE2 • Sponsor: Anhui Provincial Hospital • Aim: Disease control

Last updated Jul 12, 2026 00:00 UTC

CANCER TREATMENT-INDUCED THROMBOCYTOPENIA (CTIT)

Get alerted when new CANCER TREATMENT-INDUCED THROMBOCYTOPENIA (CTIT) trials appear

New drug aims to rescue platelet levels in leukemia patients